{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:09Z","timestamp":1790054349381,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.hjc.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T03:00:54Z","timestamp":1490670054000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients"],"prefix":"10.1016","volume":"58","author":[{"given":"Celina","family":"Wojciechowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Romuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-513X","authenticated-orcid":false,"given":"Ewa","family":"Nowalany-Kozielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-9788","authenticated-orcid":false,"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2017.03.006_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"39","key":"10.1016\/j.hjc.2017.03.006_bib2","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/eurheartj\/ehu216","article-title":"Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2017.03.006_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin,B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2017.03.006_bib4","first-page":"700","article-title":"Prediction of long-term survival In chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study","volume":"33","author":"Volpe","year":"2010","journal-title":"Clin Caridiol"},{"key":"10.1016\/j.hjc.2017.03.006_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.hjc.2016.11.027","article-title":"Myocardial inotropic reserve: An old twist that constitutes a reliable index in the modern era of heart failure","volume":"57","author":"Parthenakis","year":"2017","journal-title":"Hellenic J Cardiol."},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2010.11.005","article-title":"Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy","volume":"157","author":"Masci","year":"2012","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2017.03.006_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lecti","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscl Thromb Vasc"},{"issue":"7\u20139","key":"10.1016\/j.hjc.2017.03.006_bib9","first-page":"583","article-title":"Seeing strangers or announcing \u201cdanger\u201d: galectin-3 in two models of innate immunity","volume":"19","author":"Sato","year":"2004","journal-title":"Glycoconjugate J"},{"issue":"5","key":"10.1016\/j.hjc.2017.03.006_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.hjc.2017.03.006_bib11","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hjc.2017.03.006_bib12","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hjc.2017.03.006_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology task force on the definition and classification of Cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hjc.2017.03.006_bib14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hjc.2017.03.006_bib15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiog"},{"issue":"3","key":"10.1016\/j.hjc.2017.03.006_bib16","first-page":"418","article-title":"Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circulation: Heart Failure"},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial","volume":"14","author":"Lopez-Andr\u00e8s","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hjc.2017.03.006_bib18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.hjc.2017.03.006_bib19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Investigators. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study","volume":"58","author":"McNamara","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hjc.2017.03.006_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejheart.2007.07.010","article-title":"COMET investigators. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial","volume":"9","author":"Olsson","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.hjc.2017.03.006_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.healun.2004.07.006","article-title":"Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure","volume":"23","author":"Rothenburger","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.hjc.2017.03.006_bib22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1373\/clinchem.2007.096560","article-title":"Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure","volume":"54","author":"Mueller","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.hjc.2017.03.006_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cardfail.2008.06.415","article-title":"Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure","volume":"14","author":"Boisot","year":"2008","journal-title":"J Card Fail"},{"issue":"9","key":"10.1016\/j.hjc.2017.03.006_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.20452\/pamw.2403","article-title":"Single sST2 protein measurement predicts adverse outcomes at 1-year follow-up in patients with chronic heart failure","volume":"124","author":"Sobczak","year":"2014","journal-title":"Pol Arch Med Wew"},{"issue":"23","key":"10.1016\/j.hjc.2017.03.006_bib25","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","article-title":"MUSIC investigators. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction","volume":"54","author":"Pascual-Figal","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2017.03.006_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure circ heart fail","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hjc.2017.03.006_bib27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2014.11.003","article-title":"Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure","volume":"179","author":"Broch","year":"2015","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscl Throm Vas"},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.09.011","article-title":"Renal function largely influences Galectin-3 prognostic value in heart failure","volume":"177","author":"Zamora","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.hjc.2017.03.006_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000760","article-title":"Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure","volume":"1","author":"Gopal","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hjc.2017.03.006_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2017.03.006_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"10.1016\/j.hjc.2017.03.006_bib33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2017.03.006_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.hjc.2017.03.006_bib35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ahj.2012.08.021","article-title":"The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"164","author":"Gullestad","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.hjc.2017.03.006_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2013.07.087","article-title":"Head-to-head comparison of myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3","volume":"63","author":"Bayes-Genis","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2017.03.006_bib37","first-page":"154","article-title":"High furosemide dose has detrimental effects on survival of patients with stable heart failure","volume":"56","author":"Kapelios","year":"2015","journal-title":"Hellenic J Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966616302494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966616302494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:10:53Z","timestamp":1761099053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966616302494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1109966616302494"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2017.03.006","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}